Aug 8, 2025 04:35PM

Jun 30, 2025 06:41AM

May 14, 2025 04:15PM

Mar 13, 2025 06:49AM

Feb 14, 2025 04:15PM

Dec 13, 2024 04:30PM

Aug 9, 2024 04:20PM Edesa Biotech Reports Fiscal 3rd Quarter 2024 Results

Dec 15, 2023 04:10PM

Oct 25, 2023 09:12AM

Oct 25, 2023 09:10AM

Sep 28, 2023 08:15AM

May 11, 2023 04:30PM

Apr 4, 2023 08:45AM

Mar 15, 2023 08:13AM Edesa Biotech (EDSA) and FDA Agree on Primary Endpoint for Phase 3 ARDS Drug Study

Mar 15, 2023 08:10AM

Feb 10, 2023 09:00AM

Jan 17, 2023 08:33AM

Jan 17, 2023 08:30AM

Dec 20, 2022 08:32AM

Dec 20, 2022 08:30AM

Dec 16, 2022 09:00AM Edesa Biotech Reports Fiscal Year 2022 Results

Sep 30, 2022 08:03AM

Sep 30, 2022 08:00AM

Feb 17, 2022 08:05AM

Feb 17, 2022 08:00AM

Jan 13, 2022 07:55AM

Jun 18, 2021 07:45AM

Jun 3, 2021 07:30AM Edesa Biotech Reports Positive Interim Results in Dermatitis Trial

Mar 9, 2021 07:30AM

Feb 16, 2021 07:30AM

Jan 26, 2021 07:39AM

Jan 26, 2021 07:30AM

Oct 19, 2020 07:35AM

Oct 19, 2020 07:30AM

Aug 12, 2020 07:45AM Edesa Biotech Reports Fiscal 3rd Quarter 2020 Results

Jul 30, 2020 09:28AM

Jul 30, 2020 07:52AM

Jul 30, 2020 07:45AM

Apr 20, 2020 09:00AM

Dec 3, 2019 07:38AM

Dec 3, 2019 07:30AM

Oct 21, 2019 07:34AM Edesa Biotech (EDSA) Reports First Patient Enrollment in Phase 2b Dermatitis Study

Oct 21, 2019 07:30AM

Sep 5, 2019 07:32AM

Sep 5, 2019 07:30AM

Aug 29, 2019 08:30AM

Jul 25, 2019 07:30AM

Jun 20, 2019 07:33AM

Jun 20, 2019 07:30AM Edesa Biotech Receives Approval to Proceed with U.S. Clinical Study

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All